BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Oct 05, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Opaxio paclitaxel poliglumex: Phase II data

Additional data from an ongoing, open-label Phase II trial in 40 patients showed that Opaxio plus cisplatin and radiation produced a complete response in 8 of the first 28 patients who underwent resection....

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >